# Medsavana, S.L.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medsavana-s-l

- Industry: Healthcare IT
- Headquarters: Madrid, Spain
- Website: www.savanamed.com
- Total disclosed funding: $19M
- Latest round: Series B (Oct 15, 2020)
- Investors on record: 3

## About

Medsavana, S.L. is a healthcare technology company that leverages advanced Natural Language Processing and machine learning to convert Electronic Medical Records into actionable real-world evidence, enhancing clinical decision-making and disease management for healthcare providers and life sciences firms.Founded in 2014 in Madrid, Spain, Medsavana, S.L. specializes in transforming Electronic Medical Records into actionable insights. The company has raised EUR 23.00 mn in funding through three deals, the most recent being on April 5, 2022, led by Buenavista Equity Partners with participation from other investors. The CEO, David Flores, is one of the co-founders, alongside Alberto Ramón-Borja, Ignacio Medrano, and Jorge Guijarro.Medsavana specializes in converting Electronic Medical Records (EMR) into actionable real-world evidence (RWE) using advanced Natural Language Processing (NLP) and machine learning technologies. Its platform offers AI-generated clinical insights that enable healthcare providers to efficiently analyze clinical data, improving decision-making in patient care and enhancing disease management understanding for life sciences companies. The company supports a diverse client base, including leading pharmaceutical firms and healthcare providers across Europe, North America, and Latin America with a multi-language platform compliant with the OMOP Common Data Model.In the most recent financial year of 2023, Medsavana reported revenue of EUR 1,218,067.50 with an EBITDA of EUR -3,144,250.70. The revenue model is driven primarily by partnerships and subscription services that allow clients to access its analytical tools and services aimed at generating RWE from extensive clinical data.Following the EUR 23.00 mn funding raised on April 5, 2022, led by GED Iberian Private Equity, Medsavana plans to utilize the capital to enhance its technology and expand its management team to support growth initiatives. The company has strategies in place for international expansion and aims to enter new markets to broaden its geographic reach.

## Funding rounds

- Series B, Oct 15, 2020, $15M — Cathay Capital, Seaya Ventures, MACSF
- Series A, Aug 3, 2019, $4.3M — Seaya Ventures

## Investors

- Seaya Ventures (https://capitalatlas.ai/funds/seaya-ventures) — Series A, Series B
- Cathay Capital — Series B
- MACSF — Series B